<div id="readability-page-1"><div><p>We wouldn't blame <strong>Axogen, Inc.</strong> (NASDAQ:AXGN) shareholders if they were a little worried about the fact that Michael Dale, the President recently netted about US$1.9m selling shares at an average price of US$31.21.    That's a big disposal, and it decreased their holding size by 41%, which is notable but not too bad.</p> <p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p><h2> The Last 12 Months Of Insider Transactions At Axogen </h2> <p> Notably, that recent sale by Michael Dale is the biggest insider sale of Axogen shares that we've seen in the last year.     So we know that an insider sold shares at around the present share price of US$29.98.  While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price.  We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.   </p> <p> Insiders in Axogen didn't buy any shares in the last year.    You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below.  If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! </p><p><span> See our latest analysis for Axogen </span></p><figure><img height="872" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/20946777-insider-trading-volume-1-dark-2/1765537192786?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1642" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/20946777-insider-trading-volume-1-dark-2/1765537192786"/><figcaption>NasdaqCM:AXGN Insider Trading Volume December 12th 2025</figcaption></figure><p> I will like Axogen better if I see some big insider buys. While we wait, check out this <strong>free</strong> list of undervalued and small cap stocks with considerable, recent, insider buying. </p> <h2> Does Axogen Boast High Insider Ownership? </h2><p> For a common shareholder, it is worth checking how many shares are held by company insiders.  We usually like to see fairly high levels of insider ownership.   Axogen insiders own about US$39m worth of shares. That equates to 2.8% of the company.  While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.  </p><h2> So What Do The Axogen Insider Transactions Indicate? </h2><p> Insiders  sold stock recently, but they haven't been buying.     And even if we look at the last year, we didn't see any purchases.    Insiders own shares, but we're still pretty cautious, given the history of sales.  We'd practice some caution before buying!      While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision.     For example - Axogen has <strong>1 warning sign</strong> we think you should be aware of.  </p><p> But note: <strong>Axogen may not be the best stock to buy</strong>. So take a peek at this <strong>free</strong> list of interesting companies with high ROE and low debt. </p><p><em>For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.</em></p><div><p>Mobile Infrastructure for Defense and Disaster</p><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p><p>Get the investor briefing before the next round of contracts</p><p><span>Sponsored On Behalf of CiTech</span></p></div></div></div>

AXGN

<p>Michael Dale, President of Axogen, Inc., sold shares worth approximately $1.9 million, reducing his holding by 41%. This is the largest insider sale at Axogen in the past year. While insider selling can be concerning, the sale was at the current share price, mitigating some worry. No insider purchases were noted in the last year, and insiders own 2.8% of the company. Caution is advised for potential investors.</p>

Trade Alert: President Of Axogen Michael Dale Has Sold Stock